How a Resource-Limited Community Hospital in Thailand Transformed TB Screening With AI

Inspectra CXR assisted TB screening

Structural Pressure on a Frontline Health System

Community hospitals across Southeast Asia share a defining tension: the mandate to deliver comprehensive screening programs in settings where specialist capacity simply does not exist.

For tuberculosis, a disease where early detection is both clinically critical and a public health imperative, this tension is acute. Thailand National TB screening policies require regular chest X-ray-based screening of high-risk populations. But in community hospitals far from urban centers, the radiologist needed to read those scans is rarely present.

The consequences were predictable and serious. Without a triage mechanism, urgent and routine cases sat in the same undifferentiated queue. High-risk patients experienced delayed diagnosis. And in at least one documented case, a patient whose screening film went unread returned months later with advanced TB severe enough to require mechanical ventilation.

This wasn’t negligence, but it was math. The 30-bed community hospital has 4 general practitioners. And each doctor is expected to read around 80 chest X-ray films per day, while required to run an outpatient clinic. 

No triage. No prioritization. Every film was equal in the queue, whether it showed a healthy lung or an advanced infection. The critical and the routine were indistinguishable until someone opened each one.

Under those conditions, delays weren’t a failure of care. They were an inevitable outcome of a workflow that was not designed for constraint setting.

How Inspectra CXR Improves Clinical Workflow in Community Hospital

Inspectra CXR AI assisting TB screening in a Thai community hospital by prioritizing abnormal chest X-rays to help physicians triage patients faster.

If Inspectra CXR only presents an abnormality score for each case, it does little to enhance the overall clinical workflow. In practice, however, Inspectra CXR is designed to improve efficiency and expand screening capacity while maintaining high accuracy. This enables patients to access better care and supports timely, actionable treatment decisions.

With the support from Thailand’s National Health Security Office (NHSO), the hospital integrated Inspectra CXR, AI for chest X-ray analysis, into its workflow.

The scenario for this 30-bed community hospital was shifted from ‘every film was equal in the queue’ to ‘the critical cases cut the line to the top of the worklist.’ 

The criteria for TB screening in high-risk patients have changed based on the criteria;

High TB Risk (>50% probability) Escalated to a radiologist for review within 8 hours. No delay. No chance of it sitting unnoticed at the bottom of a pile.

Other Abnormalities Detected Flagged for physician confirmation within the week — important, but not immediately critical.

Low Risk Cleared automatically. Does not enter the radiologist’s reading queue at all.

What This Actually Changes

The value here is not simply speed. It is the quality of clinical attention that speed enables. When physicians are no longer spending cognitive effort on low-risk films, that attention is redirected toward the cases that need it most. Urgent findings are no longer dependent on where they happen to land in a queue. The system’s capacity to catch critical cases becomes structurally reliable, not a function of luck or timing.

For a resource-limited hospital serving a high-risk population, that reliability is the difference between early intervention and a patient returning on a ventilator.

AI did not replace clinical judgment here, but it made clinical judgment possible at the scale and speed the setting demands.

Facebook
Twitter
LinkedIn

Related Resources

Perceptra has been selected as a technology partner for the launch of the A.Catalyst Network Thailand Hub by AstraZeneca (Thailand), joining a global health innovation network active in more than 20 countries. This selection marks a significant recognition of Thai-developed artificial intelligence on the international stage.
เพอเซ็ปทราร่วมเป็นพันธมิตรเทคโนโลยีในการเปิดตัว A.Catalyst Network Thailand Hub โดย บริษัท แอสตร้าเซนเนก้า (ประเทศไทย) จำกัด ซึ่งเป็นส่วนหนึ่งของเครือข่ายนวัตกรรมสุขภาพระดับโลกที่ดำเนินงานในกว่า 20 ประเทศ การได้รับคัดเลือกในครั้งนี้สะท้อนถึงศักยภาพของนวัตกรรมปัญญาประดิษฐ์ (AI) ที่พัฒนาโดยคนไทย ซึ่งได้รับการยอมรับในมาตรฐานระดับสากล
เทคโนโลยี AI เข้ามามีบทบาทในการช่วยอ่านภาพเอซเรย์ปกติ ลดช่องว่างที่เป็นข้อจำกัดเดิม เพิ่มโอกาสในการพบรอยโรคในระยะเริ่มต้นมากขึ้น